Closed system production of serum eye drops using dockable saline

Author:

Kirwan Susy1ORCID,Kwan Patrick S. L.1ORCID,So Ronald1,Tuinukuafe Alice2

Affiliation:

1. Clinical Development Team New Zealand Blood Service Auckland New Zealand

2. Cellular and Tissue Laboratory New Zealand Blood Service Auckland New Zealand

Abstract

AbstractBackground and ObjectivesA fully closed system solution to manufacture serum eye drops using diluted serum has remained elusive, necessitating production steps to mitigate bacterial contamination risks in a clean suite environment, hampering production efficiency amid growing demand. We describe our recent implementation of a fully closed manufacturing process at New Zealand Blood Service.Materials and MethodsA dockable format for sterile saline manufactured to custom specifications configured with a 15‐cm tubing to enable sterile connections was sourced from a local pharmaceutical manufacturer.ResultsFrom a total of 30,168 eye drop vials manufactured since implementation, the average production time was reduced by up to 45% performed in the general laboratory environment, attributed to eliminating processes performed in a clean suite. No bacterial contamination was observed, demonstrating robust sterile connections.ConclusionDockable saline takes serum eye drops manufactured from a functionally closed system to a fully closed system, thereby enhancing patient safety, significantly reducing manufacturing time and cost and transforming production from a highly restrictive process into a portable workflow that is simple, practical and effective.

Publisher

Wiley

Subject

Hematology,General Medicine

Reference12 articles.

1. The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report;Rauz S;Eye,2017

2. Allogeneic serum eye drops: time these became the norm?

3. Serum eye drops: a survey of international production methods

4. U.S. Food & Drug Administration.FDA Premarket Notification; B. Braun Medical INC. Available from:https://www.accessdata.fda.gov/scrIpts/cdrh/cfdocs/cfpmn/pmn.cfm?id=K041415.

5. TGF-ßs stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3